STEPHANIE BEACHAM: Open Payments
NPI 1346558822 · CLEMSON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$561 in 32 payments from 14 companies in 2025. Trend: 2023 $288 · 2024 $409 · 2025 $561
Food & beverage: $561
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $164 |
| Teva Pharmaceuticals USA, Inc. | 4 | $72 |
| Neurelis, Inc. | 3 | $58 |
| Lundbeck LLC | 2 | $46 |
| ARGENX US, INC. | 1 | $30 |
| PFIZER INC. | 2 | $30 |
| Otsuka America Pharmaceutical, Inc. | 1 | $24 |
| Alexion Pharmaceuticals, Inc. | 1 | $24 |
| Novo Nordisk Inc | 1 | $21 |
| TG Therapeutics, Inc. | 1 | $21 |
Products named: AUSTEDO XR, VALTOCO, VYALEV, VYEPTI, UBRELVY, QULIPTA, VYVGART HYTRULO, ELIQUIS.
Industry payments across SC — which companies pay providers there.
